Institutional members access full text with Ovid®

Share this article on:

Treatment options in immune thrombocytopenia

Dubis, Laura MPAS, PA-C; Collins, Miranda MEd, MPAS, PA-C

Journal of the American Academy of Physician Assistants: December 2016 - Volume 29 - Issue 12 - p 59–63
doi: 10.1097/01.JAA.0000488706.57077.f3
Special Topics in Hematology

ABSTRACT: Immune thrombocytopenia (ITP) is an autoimmune condition that can cause life-threatening bleeding. ITP may develop idiopathically, after an infection or administration of a medication, or as a comorbid condition. Treatment depends on whether life-threatening, active bleeding is occurring. Although corticosteroids remain a standard of care, new medications offer patients an alternative to splenectomy when other pharmacologic treatments fail.

At the time this article was written, Laura Dubis was a student in the PA program at Marietta College in Marietta, Ohio. She now practices as a hospitalist at Winona Health in Winona, Minn. Miranda Collins is an associate professor in the PA program at Marietta College. The authors have disclosed no potential conflicts of interest, financial or otherwise.

Roy A. Borchardt, PA-C, PhD, and Michael D. Overcash, MPAS, PA-C, department editors

Copyright © 2016 American Academy of Physician Assistants
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website